Ladenburg Thalmann Downgrades United Therapeutics Corp. (UTHR) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street futures fall as oil, Treasury yields rise on Iran tensions
- Oil prices fall after hitting over one-month high; traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- Berkshire’s Abel says data centers are energy opportunity
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
United Therapeutics (UTHR) Misses Q1 EPS by 19c
April 28, 2016 9:25 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.02, $0.19 worse than the analyst estimate of $3.21. Revenue for the quarter came in at $369 million versus the consensus estimate of $397.42 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
... MoreUnited Therapeutics' (UTHR) CO-CEO and COO to Step Down
April 28, 2016 9:23 AM EDTUnited Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D. has stepped down as the company's President and Co-Chief Executive Officer and David Zaccardelli, Pharm.D. has stepped down as the company's Executive Vice President and Chief Operating Officer. These departures will become effective June 26, 2016. In addition, Dr. Jeffs will not stand for re-election to the company's Board of Directors when his current term expires at the 2016 Annual Meeting of Shareholders, which is to be held on June 21, 2016. Dr. Jeffs will become a Senior Advisor to the company.
Michael Benkowitz, the company's current... More
